Recursion Pharmaceuticals Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Recursion Pharmaceuticals's estimated revenue is currently $18.9M per year.
- Recursion Pharmaceuticals received $20.5M in venture funding in June 2018.
- Recursion Pharmaceuticals's estimated revenue per employee is $134857
- Recursion Pharmaceuticals's total funding is $141.3M.
- Recursion Pharmaceuticals has 140 Employees.
- Recursion Pharmaceuticals grew their employee count by 36% last year.
- Recursion Pharmaceuticals currently has 4 job openings.
What Is Recursion Pharmaceuticals?
Recursion Pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics. Our platform has resulted in the massive parallelization of drug discovery. We have deployed this platform in pursuit of drugs for the treatment of rare genetic diseases. We partner or out-license these leads to major pharmaceutical companies early in development. Our horizontal business model focused on discovery accelerates our impact and reduces our costs by avoiding slow and costly in-house development, and allows us to spread risk across many new therapeutic opportunities.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Recursion Pharmaceuticals News
... Leukodystrophy (MLD) Treatment Market 2019 : Global Analysis Report (ArmaGen Inc, GlaxoSmithKline Plc, Recursion Pharmaceuticals Inc).
The key players covered @ Imagia Cybernetics,Nuritas,Elsevier,Recursion Pharmaceuticals,BenevolentAI,SOPHiA GENETICS,Virvio,NuMedii ...
Recursion Pharmaceuticals also said it plans to prioritize treatments for rare diseases within its pipeline while seeking drugmaker partnerships ...
Recursion Pharmaceuticals Funding
|2017-02-10||$4.0M||Undisclosed||Square 1 Bank||Article|
|2017-10-04||$60.0M||B||Data Collective (DCVC)||Article|
|2018-06-06||$20.5M||Undisclosed||Square 1 Bank||Article|
Recursion Pharmaceuticals Executive Hires
|2018-05-02||Kevin Lynch||Chief Business Officer||Article|
|2018-05-16||Phil Carpino||Dir Chemistry||Article|
|2018-07-11||Tina Larson||Chief Operating Officer||Article|